GB9814355D0 - Polymers - Google Patents

Polymers

Info

Publication number
GB9814355D0
GB9814355D0 GBGB9814355.5A GB9814355A GB9814355D0 GB 9814355 D0 GB9814355 D0 GB 9814355D0 GB 9814355 A GB9814355 A GB 9814355A GB 9814355 D0 GB9814355 D0 GB 9814355D0
Authority
GB
United Kingdom
Prior art keywords
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB9814355.5A
Other versions
GB2324534B (en
GB2324534A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9600272.0A external-priority patent/GB9600272D0/en
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GB9814355A priority Critical patent/GB2324534B/en
Publication of GB9814355D0 publication Critical patent/GB9814355D0/en
Publication of GB2324534A publication Critical patent/GB2324534A/en
Application granted granted Critical
Publication of GB2324534B publication Critical patent/GB2324534B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9814355A 1996-01-06 1997-01-06 Composition for delivery of nucleic acid to a cell Expired - Fee Related GB2324534B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9814355A GB2324534B (en) 1996-01-06 1997-01-06 Composition for delivery of nucleic acid to a cell

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9600272.0A GB9600272D0 (en) 1996-01-06 1996-01-06 Polymers
GB9814355A GB2324534B (en) 1996-01-06 1997-01-06 Composition for delivery of nucleic acid to a cell
PCT/GB1997/000022 WO1997025067A2 (en) 1996-01-06 1997-01-06 Polymers

Publications (3)

Publication Number Publication Date
GB9814355D0 true GB9814355D0 (en) 1998-09-02
GB2324534A GB2324534A (en) 1998-10-28
GB2324534B GB2324534B (en) 2000-05-10

Family

ID=26308436

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9814355A Expired - Fee Related GB2324534B (en) 1996-01-06 1997-01-06 Composition for delivery of nucleic acid to a cell

Country Status (1)

Country Link
GB (1) GB2324534B (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1019525B (en) * 1972-03-21 1977-11-30 Ferdinando D APPARATUS AND PRODUCT METHOD TO FORM STABLE COMPLEXES OF POLY NIONS
US4093677A (en) * 1975-06-10 1978-06-06 Paolo Ferruti Macromolecular materials suitable for forming antithrombogenic prosthesis and artificial organs and process for preparing same
US5086162A (en) * 1990-04-10 1992-02-04 Texaco Chemical Company Polyether amide from polyalkylene glycol diamine and diacid mixture
EP0665729B1 (en) * 1992-09-04 2003-05-07 The General Hospital Corporation Biocompatible polymers containing diagnostic or therapeutic moieties
DE4408528A1 (en) * 1994-03-14 1995-09-28 Hoechst Ag Peptide oligonucleotide derivatives, their preparation and use
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
FR2722506B1 (en) * 1994-07-13 1996-08-14 Rhone Poulenc Rorer Sa COMPOSITION CONTAINING NUCLEIC ACIDS, PREPARATION AND USES
US5656611A (en) * 1994-11-18 1997-08-12 Supratek Pharma Inc. Polynucleotide compositions
US5998024A (en) * 1995-02-02 1999-12-07 Rainer H. Frey Biocompatible material and method of manufacture and use thereof

Also Published As

Publication number Publication date
GB2324534B (en) 2000-05-10
GB2324534A (en) 1998-10-28

Similar Documents

Publication Publication Date Title
GB9600272D0 (en) Polymers
ZA988420B (en) Novel polymers
GB9526419D0 (en) Polymers
DE69736261D1 (en) Alpha-1-6-fucosyltransferasen
GB2314583B (en) Handleset
EP0709410A3 (en) Polymers
ZA9811471B (en) Polymer
GB9608675D0 (en) Remlive
GB9716454D0 (en) Polymer
GB9620691D0 (en) Olefin polymers
SG43580A1 (en) Novel functional polymers
GB9612582D0 (en) Polymers
GB9814355D0 (en) Polymers
GB9604382D0 (en) Polymers
GB9612580D0 (en) Polymers
GB9612158D0 (en) Novel polymers
KR100266733B1 (en) Spirobiindan compounds and polymers
PL330823A1 (en) Improved autoradiohraphy
GB9700114D0 (en) Pseudo-catenane polymers
HUP0000866A3 (en) Polymers
ZA983923B (en) Biofuncational polymers
GB9700897D0 (en) Ethynylbenzine polymers
GB9727134D0 (en) Polymers
GB9720250D0 (en) Polymers
GB9718909D0 (en) Polymers

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20050106